Former Google Cloud, HPE, and BlueData Product Leader Joins Following HYCU aiR Launch to Advance Company's AI Resilience Strategy Across 100+ Workloads
Boston, Massachusetts, Aug. 19, 2026 (GLOBE N......
U.S. FDA Accepts Teva's New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome
U.S. FDA Accepts Teva's New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome
LUXEMBOURG--(BUSINESS WIRE)--SES, a global leader in space solutions, today announced an expanded strategic investment and collaboration with Elveo Mobile (Elveo), the new company created through the ......
